prednisone has been researched along with tofacitinib in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 6 (75.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fellowes, A; Hanna, DM; Hansford, JR; Mechinaud, F; Vedururu, R | 1 |
| Bernatsky, S; Curtis, JR; Xie, F; Yun, H | 1 |
| Kotwani, P; Lewin, S; Terdiman, J | 1 |
| Choi, D; Desmarais, J; Friedman, MA; Harrington, CA; Jackson, P; Le, B; Ogle, K; Rosenbaum, JT; Seifer, D; Stevens, J | 1 |
| Xu, Q; Yang, PD; Zhu, KJ | 1 |
| Ali, M; Sharma, A | 1 |
| Li, W; Li, X; Liu, H; Qian, H; Wu, F; Zhou, X; Zhou, Y | 1 |
| Ceccarelli, F; Conti, F; Garufi, C; Mancuso, S; Spinelli, FR; Truglia, S | 1 |
8 other study(ies) available for prednisone and tofacitinib
| Article | Year |
|---|---|
A unique case of refractory primary mediastinal B-cell lymphoma with JAK3 mutation and the role for targeted therapy.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Female; Gene Expression Regulation, Neoplastic; Humans; Janus Kinase 3; Lymphoma, Large B-Cell, Diffuse; Mediastinal Neoplasms; Molecular Targeted Therapy; Mutation; Piperidines; Prednisone; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Signal Transduction; Stem Cell Transplantation; Transplantation, Homologous; Vincristine | 2014 |
Brief Report: Risk of Gastrointestinal Perforation Among Rheumatoid Arthritis Patients Receiving Tofacitinib, Tocilizumab, or Other Biologic Treatments.
Topics: Abatacept; Adult; Age Factors; Aged; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis, Rheumatoid; Biological Products; Databases, Factual; Diverticulitis; Esophageal Perforation; Female; Gastroesophageal Reflux; Glucocorticoids; Humans; Incidence; Intestinal Perforation; Male; Medicare; Middle Aged; Peptic Ulcer; Piperidines; Prednisone; Proportional Hazards Models; Pyrimidines; Pyrroles; Risk Factors; Rituximab; Tumor Necrosis Factor-alpha; United States | 2016 |
Tofacitinib for Rescue Therapy in Acute Severe Ulcerative Colitis: A Real-world Experience.
Topics: Adult; Anti-Inflammatory Agents; Colectomy; Colitis, Ulcerative; Female; Humans; Immunosuppressive Agents; Infliximab; Maintenance Chemotherapy; Male; Middle Aged; Piperidines; Prednisone; Protein Kinase Inhibitors; Pyrimidines; Retreatment; Severity of Illness Index; Treatment Outcome; Young Adult | 2020 |
Tofacitinib as a Steroid-Sparing Therapy in Pulmonary Sarcoidosis, an Open-Label Prospective Proof-of-Concept Study.
Topics: Adult; Female; Glucocorticoids; Humans; Male; Middle Aged; Pilot Projects; Piperidines; Prednisone; Proof of Concept Study; Prospective Studies; Protein Kinase Inhibitors; Pyrimidines; Sarcoidosis, Pulmonary; Spirometry; Treatment Outcome | 2021 |
Tofacitinib Treatment of Refractory Cutaneous Leukocytoclastic Vasculitis: A Case Report.
Topics: Adult; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Janus Kinase Inhibitors; Piperidines; Prednisone; Pyrimidines; Skin Ulcer; Treatment Outcome; Vasculitis, Leukocytoclastic, Cutaneous; Wound Healing | 2021 |
Case Report: Home-based Management of Severe COVID-19 with Low-dose Tofacitinib.
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Inflammatory Agents; COVID-19 Drug Treatment; Cytokine Release Syndrome; Cytokines; Enoxaparin; Female; Gene Expression Regulation; Humans; Methylprednisolone; Middle Aged; Piperidines; Prednisone; Pyrimidines; SARS-CoV-2 | 2021 |
Anti-laminin γ1 (p200) pemphigoid successfully treated with tofacitinib combined with prednisone.
Topics: Autoantibodies; Autoantigens; Humans; Pemphigoid, Bullous; Piperidines; Prednisone; Pyrimidines | 2023 |
Tapering and discontinuation of glucocorticoids in patients with rheumatoid arthritis treated with tofacitinib.
Topics: Aged; Arthritis, Rheumatoid; Glucocorticoids; Humans; Middle Aged; Pilot Projects; Prednisone | 2023 |